Targeting mTOR and eIF4E: a feasible scenario in ovarian cancer therapy.
Ontology highlight
ABSTRACT: Ovarian carcinoma is one of the most common causes for cancer death in women; lack of early diagnosis and acquired resistance to platinum-based chemotherapy account for its poor prognosis and high mortality rate. As with other cancer types, ovarian cancer is characterized by dysregulated signaling pathways and protein synthesis, which together contribute to rapid cellular growth and invasiveness. The mechanistic/mammalian target of rapamycin (mTOR) pathway represents the core of different signaling pathways regulating a number of essential steps in the cell, among which protein synthesis and the eukaryotic initiation factor 4E (eIF4E), the mRNA cap binding protein, is one of its downstream effectors. eIF4E is a limiting factor in translation initiation and its overexpression is a hallmark
SUBMITTER: Romagnoli A
PROVIDER: S-EPMC9094073 | biostudies-literature | 2021
REPOSITORIES: biostudies-literature
ACCESS DATA